欢迎联系客服人员:
客服:13918293035
QQ:3001034031
客服:13917991872
QQ:3001005926
客服:15102117276
QQ:3001090745
客服:18217024652
QQ:3001084617
客服:13816009161
QQ:3001086693
客服:13795317828
QQ:3001080377
客服:15800340161
QQ:3001010259
客服:13651665725
QQ:3001028570
客服:18918753302
QQ:3001080321
客服:13916577892
QQ:3001007248
客服:15316187026
QQ:3004961006
客服:18901678489
QQ:3004909899
客服:18018502489
QQ:3004930012
客服:18019219489
QQ:3004900398
电话:021-58979353
电话:021-68920155
电话:021-68404353
邮箱:info@zzsrm.com
邮箱:tech@zzbioco.com
货号 | 简称 | 化学名 | CAS | 纯度 |
ZS-31062 | Tm-DOTA | Thulium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetate; | N/A | ≥ 94% |
ZS-31063 | Gd-DOTA | Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetate; | N/A | N/A |
ZS-31064 | Tm-DOTP | Thulium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetra(methylenephosphonate); | .30859-88-8 | N/A |
ZS-31065 | Tm-DOTMA | Thulium (III) (1R, 4R, 7R, 10R)-α, α’, α”, α’”-Tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; | N/A | ≥ 94% |
ZS-31066 | Eu-DOTA-4AmC | Europium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakis(acetamidoacetic acid); | N/A | ≥ 95% |
ZS-31067 | Tm-p-SCN-Bn-DOTA | Thulium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-_x000D_ tetraazacyclododecane-1,4,7,10-tetraacetic acid; |
N/A | ≥ 94% |
ZS-31068 | Gd-p-SCN-Bn-DOTA | Gadolinium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; | N/A | ≥ 94% |
ZS-31069 | Ho-p-SCN-Bn-DOTA | Holmium (III) S-2-(4-isothiocyanatobenzyl)-1,4,7,10-_x000D_ tetraazacyclododecane-1,4,7,10-tetraacetic acid; |
N/A | ≥ 94% |
ZS-31070 | Tm-Maleimido-DOTA | Thulium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-_x000D_ maleimidoethylacetamide; |
N/A | ≥ 94% |
ZS-31071 | Ho-Maleimido-DOTA | Holmium (III) 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-_x000D_ 10-maleimidoethylacetamide; |
N/A | ≥ 94% |
ZS-31072 | Gd-DO3A-Butylamine | Gadolinium (III) 1,4,7,10-Tetraazacyclododecane-1,4,7-tris(acetic acid)-10-(4-aminobutyl)acetamide; | N/A | ≥ 94% |